Back to News
Market Impact: 0.5

Earnings call transcript: Forrester Q2 2025 earnings beat forecasts

FORRING
Corporate EarningsCompany FundamentalsCorporate Guidance & OutlookAnalyst EstimatesArtificial IntelligenceMarket Technicals & FlowsManagement & GovernanceEconomic Data
Earnings call transcript: Forrester Q2 2025 earnings beat forecasts

Forrester Research Inc. (FORR) reported Q2 2025 earnings that slightly exceeded analyst forecasts, with EPS at $0.51 and revenue at $111.7 million. Despite this beat, the stock declined 0.21% in after-hours trading, approaching its 52-week low, as the company experienced an 8% year-over-year revenue decrease across all segments and projected a challenging 2025 with a 5-8% revenue decline. The firm attributes this to ongoing economic uncertainty and sales conversion challenges, particularly in its events business, though it is maintaining its full-year EPS and operating margin guidance while emphasizing new product innovations like its iZOLA AI tool and emerging momentum in the government sector.

Analysis

Forrester Research (FORR) reported a marginal beat on its Q2 2025 earnings, with EPS of $0.51 against a $0.50 forecast and revenue of $111.7 million slightly surpassing the $111.14 million expectation. However, these minor positive surprises were overshadowed by significant fundamental weaknesses, leading to a 0.21% stock decline in after-hours trading. The core issue is a sharp 8% year-over-year revenue contraction, with declines across all segments: research (-7%), consulting (-5%), and a particularly severe 23% drop in the events business. The company's forward guidance reinforces this negative trend, with a tightened full-year 2025 revenue forecast projecting a 5% to 8% decline. Management attributes the headwinds to economic uncertainty impacting client spending but has also identified internal operational challenges, specifically in sales conversion despite a 15% quarter-over-quarter pipeline increase. While the company is maintaining its full-year EPS guidance of $1.20-$1.35 and operating margin of 8-9%, this appears reliant on cost controls, evidenced by a 12% YoY headcount reduction, rather than top-line recovery. Potential bright spots include a strong balance sheet with $135 million in cash against $35 million in debt, plans to reinstate a stock buyback program, and growing adoption of its iZOLA AI tool, but these are currently insufficient to offset the broad-based revenue erosion.